FDA May Reclassify ECT Devices
$ 176.99
-
By A Mystery Man Writer
-
-
5(413)
Product Description
The FDA may reclassify electroconvulsive therapy devices from class III to class II. The FDA is accepting public comments on the change until March 28.
ECT Device Manufacturer Admits Brain Damage as a Risk of
10 Facts You May Not Know About Electroconvulsive Therapy (ECT
MECTA Electroshock Device Manufacturer Files for Bankruptcy as its
FDA Looks to Expand Electroshock Use Despite Significant Risks and
Key updates in the clinical application of electroconvulsive
FDA Downgrades Cranial Electrotherapy Devices To Class II
ECT: Dangerous on Either Side of the Pond
ECT: Dangerous on Either Side of the Pond
